New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build

New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions

ValueSet: NZ WHO endocrine and neuroendocrine adrenal gland including adrenal medulla site histology

Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-site-histology Version: 0.1.0
Active as of 2024-11-11 Computable Name: canshare-who-endo-neuroendo-adrenal-site-histology
Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-who-endo-neuroendo-adrenal-site-histology

Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition)5. Adrenal gland tumours, 6. Adrenal medulla and extra-adrenal paraganglia tumours 9. Mesenchymal and stromal tumours, 10. Haematolymphoid tumours and 11. Germ cell tumours or an 'Other' value.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

Generated Narrative: ValueSet canshare-who-endo-neuroendo-adrenal-site-histology

version: 1; Last updated: 2024-11-05 17:10:23+1300; Language: en-x-sctlang-23162100-0210105

  • Include codes fromhttp://snomed.info/sct where constraint = ^380951000210104 |New Zealand World Health Organization classification of tumors 5th edition endocrine and neuroendocrine adrenal gland histology reference set (foundation metadata concept)| OR ^380961000210101 |New Zealand World Health Organization classification of tumors 5th edition endocrine and neuroendocrine adrenal medulla and extra-adrenal paraganglia histology reference set (foundation metadata concept)| OR ^380991000210106 |New Zealand World Health Organization classification of tumors 5th edition endocrine and neuroendocrine mesenchymal and stromal histology reference set (foundation metadata concept)| OR ^381001000210105 |New Zealand World Health Organization classification of tumors 5th edition endocrine and neuroendocrine hematolymphoid histology reference set (foundation metadata concept)| OR ^381011000210107 |New Zealand World Health Organization classification of tumors 5th edition endocrine and neuroendocrine germ cell histology reference set (foundation metadata concept)| OR 74964007 |Other|

 

Expansion

Generated Narrative: ValueSet canshare-who-endo-neuroendo-adrenal-site-histology

version: 1; Last updated: 2024-11-05 17:10:23+1300; Language: en-x-sctlang-23162100-0210105

Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024

This value set contains 79 concepts

CodeSystemDisplay - English (English, en)
  2348006http://snomed.info/sctAdenomatoid tumour
  2227007http://snomed.info/sctAdrenal cortical carcinoma
  381691000210107http://snomed.info/sctAdrenal cyst
  381741000210105http://snomed.info/sctAdrenal granulosa cell tumor
  381731000210102http://snomed.info/sctAdrenal Leydig cell tumor
  299751000210100http://snomed.info/sctAdrenal rest
  381701000210107http://snomed.info/sctAdrenocortical nodular disease
  63449009http://snomed.info/sctAlveolar rhabdomyosarcoma
  863926008http://snomed.info/sctAngiosarcoma
  1156661006http://snomed.info/sctBenign adrenal cortical adenoma
  295121000210107http://snomed.info/sctBenign arteriovenous haemangioma
  1340048006http://snomed.info/sctBenign glomus tumour
  1336225003http://snomed.info/sctBenign granular cell tumour
  253053003http://snomed.info/sctBenign haemangioma
  253057002http://snomed.info/sctBenign lymphangioma
  1156930004http://snomed.info/sctBenign neurofibroma
  301281000210108http://snomed.info/sctBenign solitary fibrosis tumour
  83343001http://snomed.info/sctCapillary haemangioma
  33377007http://snomed.info/sctCavernous haemangioma
  1156971005http://snomed.info/sctChoriocarcinoma
  817953005http://snomed.info/sctComposite paraganglioma
  430111000210101http://snomed.info/sctComposite paraganglioma and ganglioneuroblastoma
  430101000210103http://snomed.info/sctComposite paraganglioma and ganglioneuroma
  430121000210106http://snomed.info/sctComposite paraganglioma and neuroblastoma
  817952000http://snomed.info/sctComposite phaeochromocytoma
  430071000210106http://snomed.info/sctComposite phaeochromocytoma and ganglioneuroblastoma
  430061000210100http://snomed.info/sctComposite phaeochromocytoma and ganglioneuroma
  430091000210105http://snomed.info/sctComposite phaeochromocytoma and malignant peripheral nerve sheath tumour
  430081000210108http://snomed.info/sctComposite phaeochromocytoma and neuroblastoma
  237751000http://snomed.info/sctCongenital adrenal hyperplasia
  476731000210106http://snomed.info/sctConventional adrenal cortical carcinoma
  1172695008http://snomed.info/sctDiffuse large B cell lymphoma
  28047004http://snomed.info/sctEmbryonal carcinoma
  14269005http://snomed.info/sctEmbryonal rhabdomyosarcoma
  74409009http://snomed.info/sctEndodermal sinus tumour
  703711007http://snomed.info/sctErdheim-Chester disease
  128816008http://snomed.info/sctFollicular dendritic cell sarcoma
  53801007http://snomed.info/sctGanglioneuroma
  28307001http://snomed.info/sctGerminoma
  703603008http://snomed.info/sctGlomangiomatosis
  1293211005http://snomed.info/sctGlomus tumour of uncertain malignant potential
  128908003http://snomed.info/sctGlomus tumour, malignant
  381791000210101http://snomed.info/sctGlomuvenous malformation
  13238004http://snomed.info/sctGranular cell tumour, malignant
  10743271000119103http://snomed.info/sctIgG4 related disease
  822951003http://snomed.info/sctIntermixed ganglioneuroblastoma
  110450007http://snomed.info/sctLangerhans' cell histiocytosis
  1162890002http://snomed.info/sctLeiomyoma
  1163022006http://snomed.info/sctLeiomyosarcoma
  134328007http://snomed.info/sctLipoma
  827161000http://snomed.info/sctMalignant immature teratoma
  1162635006http://snomed.info/sctMalignant melanoma
  19897006http://snomed.info/sctMalignant peripheral nerve sheath tumour
  29370006http://snomed.info/sctMalignant phaeochromocytoma
  1292991006http://snomed.info/sctMalignant solitary fibrous tumour
  295271000210100http://snomed.info/sctMalignant teratoma with somatic-type malignancy
  128803008http://snomed.info/sctMarginal zone B-cell lymphoma
  295191000210105http://snomed.info/sctMature benign teratoma
  32844007http://snomed.info/sctMixed germ cell tumour
  20810002http://snomed.info/sctMyelolipoma
  476751000210100http://snomed.info/sctMyxoid adrenal cortical carcinoma
  87364003http://snomed.info/sctNeuroblastoma
  822950002http://snomed.info/sctNodular ganglioneuroblastoma
  476741000210103http://snomed.info/sctOncocytic adrenal cortical carcinoma
  74964007http://snomed.info/sctOther
  52205002http://snomed.info/sctParasympathetic paraganglioma
  703604002http://snomed.info/sctPerivascular epithelioid tumour, benign
  77455004http://snomed.info/sctPleomorphic rhabdomyosarcoma
  30924005http://snomed.info/sctRhabdomyosarcoma
  1295376005http://snomed.info/sctRosai-Dorfman disease
  476761000210102http://snomed.info/sctSarcomatoid adrenal cortical carcinoma
  985004http://snomed.info/sctSchwannoma
  1332419003http://snomed.info/sctSex cord-stromal tumour
  128736003http://snomed.info/sctSolitary fibrous tumour
  301441000210102http://snomed.info/sctSpindle cell and/or sclerosing rhabdomyosarcoma
  24327009http://snomed.info/sctStruma ovarii
  18854008http://snomed.info/sctStruma ovarii, malignant
  31794002http://snomed.info/sctSympathetic paraganglioma
  56468002http://snomed.info/sctVenous haemangioma

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code